School of Medicine
Showing 21-40 of 49 Results
-
Shingo Narita
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
Cardiologist (Japan) -
Chikage Noishiki, MD, PhD
Postdoctoral Scholar, Cardiovascular Institute
BioDoctor of Philosophy, Nippon Medical School, Tokyo, Japan (2019)
Doctor of Medicine, Dokkyo university, Tochigi, Japan (2010)
Board Certified in Plastic and Reconstructive Surgery, Japan (2020)
Fellowship, Plastic and Reconstructive Surgery, Nippon Medical School, Tokyo, Japan (2016) -
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes. -
Carlos Vera
Postdoctoral Scholar, Cardiovascular Institute
BioCarlos obtained his B.S. in Industrial Biotechnology from the University of Puerto Rico at Mayaguez. He received his PhD from the University of Colorado at Boulder working with Dr. Leslie Leinwand on myosin myopathies. His dissertation focused on analyzing the effects on myosin's cross-bridge cycle from mutations associated to Hypertrophic (HCM) and Dilated (DCM) cardiomyopathies. For his postdoc he will focus on disease mechanisms that can influence severity.
-
Xiaokang Wu
Postdoctoral Scholar, Cardiovascular Institute
BioAs a driven and inquisitive physician-scientist with a diverse background, Dr. Wu's research is centered on cardiovascular disease modeling (utilizing rodents and stem cells), molecular pathology, clinical genomics, and the development of novel therapeutics for cardiovascular diseases. I bring extensive experience in wet-lab experimentation, encompassing fundamental biomolecular techniques, cell culture, animal handling, cell and gene therapies, as well as large-scale next-generation sequencing (NGS) library preparation. Her multicultural exposure, coupled with advanced scientific training, equips me with a distinctive capacity for swift adaptation to new environments and tackling a wide range of projects. Currently, Dr. Wu spearheads research on transthyretin cardiac amyloidosis (ATTR), a rare and devastating protein misfolding disease. Utilizing iPSC, animal models, and human samples, her pioneering work promises significant insights into this life-threatening condition, aiming to enhance patient outcomes.
